Loprox: profile and news

(PZ) Medicis Announces FDA Approval of Broader Indication for ... Mar 2, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Houston Chronicle,

THE MANY PROBLEMS OF OILY SKIN Feb 6, 2006
...the skin yeast. Ketoconazole (Nizoral) and ciclopirox (Loprox) are available in foams, liquids, creams and ointments. The choice ... - Charlotte Sun-Herald,

The many problems of oily skin Feb 7, 2006
Ketoconazole (Nizoral) and ciclopirox (Loprox) are available in foams, liquids, creams and ointments. Both of these medicines require a prescription. ... - Sarasota Herald-Tribune,

Medicis Board Unanimously Rejects Mentor Proposal Nov 20, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Business Wire (press release),

Medicis Reports First Quarter Fiscal 2006 Financial Results Nov 8, 2005
...associated with the outlicensing of ORAPRED(R). At the end of first quarter fiscal 2006, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R ... - Business Wire (press release),

Medicis to Present at UBS Global Life Sciences Conference Sep 26, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - PharmaLive.com (press release),

Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds ... Sep 6, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Business Wire (press release),

Medicis Reports Fourth Quarter and Year-End Fiscal 2005 Financial ... Sep 1, 2005
At the end of the fourth quarter, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R), PLEXION(R), RESTYLANE(R), TRIAZ(R) and VANOS(TM). ... - Business Wire (press release),

Taro Receives Approval for Ciclopirox Topical Suspension USP, 0.77 ... Aug 10, 2005
...the skin. The Taro product is bioequivalent to Medicis Pharmaceutical Corp.'s Loprox(R) Topical Suspension, 0.77%. According to ... - Genetic Engineering News,

Intertrigo and Common Secondary Skin Infections Aug 30, 2005
Candida infections should be managed topically with antifungal lotions, creams, or ointments (eg, imidazoles, terbinafine [Lamisil], ciclopirox [Loprox]). ... - American Family Physician

Taro Reports Record Sales for Second Quarter and First Half Jul 28, 2005
...the skin. This prescription pharmaceutical product is bioequivalent to Medicis Pharmaceutical Corp.'s Loprox(R) Topical Cream. In ... - Business Wire (press release)

Medicis to Present at Banc of America Securities 2005 Specialty ... Jul 25, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Business Wire (press release) <**results**>

Medicis Declares Cash Dividend Jun 15, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Business Wire (press release)

Is Guessing Someone's Age the New American Pastime? Jun 13, 2005
...of the full impact on its business of the approval of competitive generic versions of its core brands, including DYNACIN(R) Tablets and/or LOPROX(R), or any ... - PR Newswire (press release)

Taro gets FDA OK for generic Loprox Apr 14, 2005
...skin fungal infections. The cream is the generic equivalent of Medicis Pharmaceutical Corp.'s Loprox Topical Cream. According to ... - BusinessWeek

Medicis Reports Third Quarter Fiscal 2005 Financial Results Apr 21, 2005
At the end of the third quarter, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R), PLEXION(R), RESTYLANE(R), TRIAZ(R) and VANOS(TM). ... - PharmaLive.com

Medicis Announces Third Quarter Fiscal 2005 Conference Call and ... Apr 18, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Genetic Engineering News

Taro Reports First Quarter 2005 Results Apr 26, 2005
...the skin. This prescription pharmaceutical is bioequivalent to Medicis Pharmaceutical Corp.'s Loprox(R) Topical Cream. Taro currently ... - Business Wire

Medicis Pharmaceutical says plans to buy Inamed still good Apr 21, 2005
But he said sales in all the company’s core products, from acne medication Dynacin to Loprox, a treatment for skin infections, were up. ... - East Valley Tribune

Taro Receives Approval for Ciclopirox Olamine Cream USP, 0.77% ... Apr 14, 2005
...of the skin. The Taro product is bioequivalent to Medicis Pharmaceutical Corp.'s Loprox(R) Topical Cream. According to industry ... - Genetic Engineering News

Struggling workers lower tax bill Apr 20, 2005
The drug is a generic version of Medicis Pharmaceutical Corp's Loprox Topical Cream used to treat fungal infections of the skin. ... - The Journal News.com,

Market For Skin-Care Products Shifts Toward Specialty Pharma Mar 12, 2005
...and Amgen. (AMGN). Topical anti-fungals, such as Medicis' Loprox, also represent a large and growing market. Outside of psoriasis ... - Investor's Business Daily (subscription)

Seeing Through the Flakes Feb 22, 2005
Prescription shampoos that contain antifungals, such as ciclopirox (LOPROX(R) Shampoo, Medicis Pharmaceutical Corp.) are proven to eliminate the fungus. ... - PR Newswire (press release)

Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder Feb 18, 2005
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Business Wire (press release),

Medicis Announces the Launch of Restylane Rewards - First-Ever ... Mar 2, 2005
...of the full impact on its business of the approval of competitive generic versions of its core brands, including DYNACIN(R) Tablets and/or LOPROX(R), or any ... - PharmaLive.com (press release),